MREO
Price
$3.11
Change
+$0.19 (+6.51%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
480.95M
62 days until earnings call
TERN
Price
$4.65
Change
-$0.02 (-0.43%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
394.12M
68 days until earnings call
Ad is loading...

MREO vs TERN

Header iconMREO vs TERN Comparison
Open Charts MREO vs TERNBanner chart's image
Mereo BioPharma Group
Price$3.11
Change+$0.19 (+6.51%)
Volume$67.52K
Capitalization480.95M
Terns Pharmaceuticals
Price$4.65
Change-$0.02 (-0.43%)
Volume$31.06K
Capitalization394.12M
MREO vs TERN Comparison Chart
Loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MREO vs. TERN commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and TERN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (MREO: $2.92 vs. TERN: $4.67)
Brand notoriety: MREO and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 203% vs. TERN: 65%
Market capitalization -- MREO: $480.95M vs. TERN: $394.12M
MREO [@Biotechnology] is valued at $480.95M. TERN’s [@Biotechnology] market capitalization is $394.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, MREO is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • MREO’s TA Score: 4 bullish, 3 bearish.
  • TERN’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both MREO and TERN are a good buy in the short-term.

Price Growth

MREO (@Biotechnology) experienced а -3.63% price change this week, while TERN (@Biotechnology) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.92%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was -1.05%.

Reported Earning Dates

MREO is expected to report earnings on May 14, 2025.

TERN is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+3.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($481M) has a higher market cap than TERN($394M). TERN YTD gains are higher at: -15.704 vs. MREO (-16.571). MREO has higher annual earnings (EBITDA): -43.41M vs. TERN (-99.08M). TERN has more cash in the bank: 373M vs. MREO (80.5M). TERN has less debt than MREO: TERN (1.31M) vs MREO (6.68M). MREO has higher revenues than TERN: MREO (1M) vs TERN (0).
MREOTERNMREO / TERN
Capitalization481M394M122%
EBITDA-43.41M-99.08M44%
Gain YTD-16.571-15.704106%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash80.5M373M22%
Total Debt6.68M1.31M512%
TECHNICAL ANALYSIS
Technical Analysis
MREOTERN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
80%
Momentum
ODDS (%)
Bullish Trend 16 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 16 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
82%
Bearish Trend 16 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
83%
Bearish Trend 16 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
87%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 16 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 16 days ago
86%
View a ticker or compare two or three
Ad is loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCAKX44.640.30
+0.68%
Fidelity Capital Appreciation K
MDCPX26.30N/A
N/A
BlackRock Sustainable Balanced Inv A
GAAEX5.16-0.01
-0.19%
Guinness Atkinson Alternative Energy
BPIRX13.99-0.05
-0.36%
Boston Partners Long/Short Rsrch Instl
REAYX23.74-0.14
-0.59%
Russell Inv Equity Income Y

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-2.34%
MDGL - MREO
37%
Loosely correlated
+5.74%
TERN - MREO
36%
Loosely correlated
+4.94%
INZY - MREO
35%
Loosely correlated
-3.70%
XERS - MREO
32%
Poorly correlated
-1.50%
ARRY - MREO
30%
Poorly correlated
-6.38%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with PRME. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+4.94%
PRME - TERN
42%
Loosely correlated
+9.28%
NKTX - TERN
40%
Loosely correlated
+1.64%
AURA - TERN
39%
Loosely correlated
N/A
AMLX - TERN
39%
Loosely correlated
+0.87%
RXRX - TERN
38%
Loosely correlated
+8.87%
More